SALL4 Antibody (SALL4/7301R) [DyLight 755]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-21112IR
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunohistochemistry-Paraffin
Label
DyLight 755 (Excitation = 754 nm, Emission = 776 nm)
Antibody Source
Recombinant Monoclonal Mouse IgG1 kappa Clone # SALL4/7301R
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for SALL4 Antibody (SALL4/7301R) [DyLight 755]
Immunogen
Recombinant fragment (around aa100-300) of human SALL4 protein (exact sequence is proprietary)
Localization
Nucleus.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1 kappa
Applications for SALL4 Antibody (SALL4/7301R) [DyLight 755]
Application
Recommended Usage
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: SALL4
Long Name
Sal-like 4
Alternate Names
DRRS, HSAL4, ZNF797
Gene Symbol
SALL4
Additional SALL4 Products
Product Documents for SALL4 Antibody (SALL4/7301R) [DyLight 755]
Product Specific Notices for SALL4 Antibody (SALL4/7301R) [DyLight 755]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...